RE:RE:RE:RE:RE:RE:RE:RE:Dermal Injector Roll-outInv3strr wrote: lv_426 wrote:
Again I dont doubt what your saying, you seem to have firsthand knowledge of attaining a CE mark. My point is that replicel release info that is misleading to the average investor. Misleading in the respect of not giving specifics so we have to make assumptions
My guess is anything past 2020 or 2021 is unknown to them as much as us... like we can guess whats going to happen and they have a really good idea but past 2020 is not easy to know.
We can know whats happening in 2020 with pretty good confidence..
1 - the RCI-02 will hit the market. Its already almost there ... The commercial grade devices are ordered, AMI is the best in the industry and they are applying for the CE mark, Yofoto is ready to sell in HK and China, Damien King is an executive of Mertz and other pharma companies and he's finding partners in Europe and USA., replicel has enough $ to get the RCI to market.. so the RCI hitting the market in 2020 is a really really likely scenario. That means revenue.
2 - Japanese clinical approval in Japan is almost done for skin and tendon so that's really likely to be hitting market end of 2020... the safety tests already done with good results.... lots of japanese cell companies in japan and they are going to want to do the phase 1 clinical study for skin and tendon in japan 'cause after that they can go right to market... So its really really likely that this will be a partnership or at least have japanese approval.
3 - Yofoto clnicial tests in China start.. they already have the multi million $ facility built.. maybe they already started clinical testing..
Could be more in 2020.... but these are big big events cause #1 is revenue and #2 is revenue and that means replicel is going to have a good future.
1) There is no guarantee the injector will hit the market. There be all sorts of issues that need to be dealt with. Also how says they have enough money? Lee? haha. I wouldn't be surprised if the was another placement within the next six weeks. 2)Who says clinical approval in Japan is almost done? Lee? haha. Who would want to sign a contract with replicel when the treated Shiseido so poorly? They would certainly be very leery, and I doubt they give such a sweetheart deal as Shiseido did in 2013. 3) YOFOTO "maybe" ready to start clinically testing. Basically wishful thinking on your part. If you have been invested in replicel as long as I have then you would know the only time you can believe management is when an event actually happens. All of their "updates" have fallen WAY short